Gregory Gores

Author PubWeight™ 21.55^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	New staging system and a registry for perihilar cholangiocarcinoma.	Hepatology	2011	2.89
2	Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.	Hepatology	2010	2.55
3	Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.	J Clin Oncol	2010	2.51
4	Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.	Am J Gastroenterol	2003	2.18
5	Commentary: Gastroenterology and hepatology: an evolving marriage, not an imminent divorce.	Am J Gastroenterol	2009	2.08
6	Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.	Am J Physiol Gastrointest Liver Physiol	2011	1.85
7	Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches.	Hepatology	2011	1.57
8	Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization.	Liver Transpl	2004	1.47
9	"Pardon the interruption": comments on the International Liver Cancer Association Fourth Annual Conference, 2010. Is there really no role for liver biopsy interpretation in liver cancer?	Hepatology	2011	1.40
10	Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.	Cancer Detect Prev	2004	1.01
11	Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.	Lab Invest	2012	0.89
12	Hilar cholangiocarcinoma.	J Gastrointest Surg	2004	0.89
13	Role for Krüppel-like transcription factor 11 in mesenchymal cell function and fibrosis.	PLoS One	2013	0.86